CD89 Is a Potent Innate Receptor for Bacteria and Mediates Host Protection from Sepsis.

[1]  E. Daugas,et al.  Lyn and Fyn function as molecular switches that control immunoreceptors to direct homeostasis or inflammation , 2017, Nature Communications.

[2]  I. Velasco,et al.  Negative regulation of bacterial killing and inflammation by two novel CD16 ligands , 2016, European journal of immunology.

[3]  R. Bellomo,et al.  The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3). , 2016, JAMA.

[4]  J. Cambier,et al.  Of ITIMs, ITAMs, and ITAMis: revisiting immunoglobulin Fc receptor signaling , 2015, Immunological reviews.

[5]  A. Zuercher,et al.  Reversal of Arthritis by Human Monomeric IgA Through the Receptor‐Mediated SH2 Domain–Containing Phosphatase 1 Inhibitory Pathway , 2015, Arthritis & rheumatology.

[6]  N. V. van Sorge,et al.  Bacterial Immune Evasion through Manipulation of Host Inhibitory Immune Signaling , 2015, PLoS pathogens.

[7]  A. Brenkman,et al.  Antibody-Opsonized Bacteria Evoke an Inflammatory Dendritic Cell Phenotype and Polyfunctional Th Cells by Cross-Talk between TLRs and FcRs , 2015, The Journal of Immunology.

[8]  P. Bruhns,et al.  Shifting FcγRIIA-ITAM from activation to inhibitory configuration ameliorates arthritis. , 2014, The Journal of clinical investigation.

[9]  C. Deutschman,et al.  Sepsis: current dogma and new perspectives. , 2014, Immunity.

[10]  N. Heming,et al.  Anti-inflammatory role of the IgA Fc receptor (CD89): from autoimmunity to therapeutic perspectives. , 2013, Autoimmunity reviews.

[11]  Bernadette A. Thomas,et al.  Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010 , 2012, The Lancet.

[12]  Xiaoming Pang,et al.  Epigallocatechin-3-gallate inhibits angiotensin II and interleukin-6-induced C-reactive protein production in macrophages , 2012, Pharmacological reports : PR.

[13]  M. Cogné,et al.  Transglutaminase is essential for IgA nephropathy development acting through IgA receptors , 2012, The Journal of experimental medicine.

[14]  B. Crestani,et al.  IgG1 and IVIg induce inhibitory ITAM signaling through FcγRIII controlling inflammatory responses. , 2012, Blood.

[15]  Jelena S. Bezbradica,et al.  Role of ITAM signaling module in signal integration. , 2012, Current opinion in immunology.

[16]  Y. Tomino,et al.  Negative regulation of inflammatory responses by immunoglobulin A receptor (FcαRI) inhibits the development of Toll‐like receptor‐9 signalling‐accelerated glomerulonephritis , 2011, Clinical and experimental immunology.

[17]  J. Bakema,et al.  The human immunoglobulin A Fc receptor FcαRI: a multifaceted regulator of mucosal immunity , 2011, Mucosal Immunology.

[18]  T. Arimoto,et al.  Surface Lipoprotein PpiA of Streptococcus mutans Suppresses Scavenger Receptor MARCO-Dependent Phagocytosis by Macrophages , 2011, Infection and Immunity.

[19]  Jinghua Lu,et al.  Recognition and functional activation of the human IgA receptor (FcαRI) by C-reactive protein , 2011, Proceedings of the National Academy of Sciences.

[20]  C. Mold,et al.  Pentraxins (CRP, SAP) in the process of complement activation and clearance of apoptotic bodies through Fcγ receptors , 2011, Current opinion in organ transplantation.

[21]  T. N. Rao,et al.  No Reduction of Atherosclerosis in C-reactive Protein (CRP)-deficient Mice , 2010, The Journal of Biological Chemistry.

[22]  E. López-Granados,et al.  Infection outcomes in patients with common variable immunodeficiency disorders: relationship to immunoglobulin therapy over 22 years. , 2010, The Journal of allergy and clinical immunology.

[23]  M. Benhamou,et al.  Inhibitory ITAMs as novel regulators of immunity , 2009, Immunological reviews.

[24]  D. Furst.  Serum immunoglobulins and risk of infection: how low can you go? , 2009, Seminars in arthritis and rheumatism.

[25]  Jinghua Lu,et al.  Structural recognition and functional activation of FcγR by innate pentraxins , 2008, Nature.

[26]  M. Benhamou,et al.  Inhibitory ITAMs: a matter of life and death. , 2008, Trends in immunology.

[27]  I. Velasco,et al.  CD16 promotes Escherichia coli sepsis through an FcRγ inhibitory pathway that prevents phagocytosis and facilitates inflammation , 2007, Nature Medicine.

[28]  R. Medzhitov.  Recognition of microorganisms and activation of the immune response , 2007, Nature.

[29]  F. Vrtovsnik,et al.  Fcα receptor I activation induces leukocyte recruitment and promotes aggravation of glomerulonephritis through the FcRγ adaptor , 2007 .

[30]  C. Abram,et al.  The Expanding Role for ITAM-Based Signaling Pathways in Immune Cells , 2007, Science's STKE.

[31]  L. Lanier,et al.  Inhibition of Immune Responses by ITAM-Bearing Receptors , 2006, Science's STKE.

[32]  L. Lanier,et al.  Role of ITAM‐containing adapter proteins and their receptors in the immune system and bone , 2005, Immunological reviews.

[33]  R. Monteiro,et al.  Differential expression and function of IgA receptors (CD89 and CD71) during maturation of dendritic cells , 2004, Journal of leukocyte biology.

[34]  I. Velasco,et al.  Enhanced expression of Fc alpha receptor I on blood phagocytes of patients with gram-negative bacteremia is associated with tyrosine phosphorylation of the FcR-gamma subunit. , 2001, Shock.

[35]  S. Akira,et al.  Roles of Toll‐like receptors in innate immune responses , 2001, Genes to cells : devoted to molecular & cellular mechanisms.

[36]  F. Geissmann,et al.  A Subset of Human Dendritic Cells Expresses IgA Fc Receptor (CD89), Which Mediates Internalization and Activation Upon Cross-Linking by IgA Complexes , 2001, The Journal of Immunology.

[37]  R. Monteiro,et al.  Fcα Receptor (Cd89) Mediates the Development of Immunoglobulin a (Iga) Nephropathy (Berger's Disease) , 2000, The Journal of Experimental Medicine.

[38]  Marjolein van Egmond,et al.  FcαRI-positive liver Kupffer cells: Reappraisal of the function of immunoglobulin A in immunity , 2000, Nature Medicine.

[39]  L. Notarangelo,et al.  Diagnostic Criteria for Primary Immunodeficiencies , 1999 .

[40]  J. Dunlop,et al.  Identification of Residues in the CH2/CH3 Domain Interface of IgA Essential for Interaction with the Human Fcα Receptor (FcαR) CD89* , 1999, The Journal of Biological Chemistry.

[41]  D. Goldblatt,et al.  A Flow Cytometric Opsonophagocytic Assay for Measurement of Functional Antibodies Elicited after Vaccination with the 23-Valent Pneumococcal Polysaccharide Vaccine , 1999, Clinical Diagnostic Laboratory Immunology.

[42]  R. Monteiro,et al.  Alternative Endocytic Pathway for Immunoglobulin A Fc Receptors (CD89) Depends on the Lack of FcRγ Association and Protects against Degradation of Bound Ligand* , 1999, The Journal of Biological Chemistry.

[43]  C. Maliszewski,et al.  Lipopolysaccharide and cytokine augmentation of human monocyte IgA receptor expression and function. , 1994, Journal of immunology.

[44]  M. Cooper,et al.  Molecular heterogeneity of Fc alpha receptors detected by receptor-specific monoclonal antibodies. , 1992, Journal of immunology.

[45]  M. Reth.  Antigen receptor tail clue , 1989, Nature.

[46]  B. Bake,et al.  Impaired lung function in patients with IgA deficiency and low levels of IgG2 or IgG3. , 1985, The New England journal of medicine.

[47]  M. Daha,et al.  Requirement of extracellular complement and immunoglobulin for intracellular killing of micro-organisms by human monocytes. , 1979, The Journal of clinical investigation.

[48]  D. Rittirsch,et al.  Immunodesign of experimental sepsis by cecal ligation and puncture , 2008, Nature Protocols.

[49]  I. Moura,et al.  Identification of FcαRI as an Inhibitory Receptor that Controls Inflammation: Dual Role of FcRγ ITAM , 2005 .

[50]  I. Moura,et al.  Identification of FcalphaRI as an inhibitory receptor that controls inflammation: dual role of FcRgamma ITAM. , 2005, Immunity.

[51]  R. Monteiro,et al.  IgA Fc receptors. , 2003, Annual review of immunology.